FR2181738A1 - - Google Patents

Info

Publication number: FR2181738A1
Authority: FR; France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

FR7305356A

Other languages

Other versions

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Inc

Original Assignee

Pfizer Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-02-23

Filing date

1973-02-15

Publication date

1973-12-07

1973-02-15 Application filed by Pfizer Inc filed Critical Pfizer Inc

1973-12-07 Publication of FR2181738A1 publication Critical patent/FR2181738A1/fr

1976-03-05 Application granted granted Critical

1976-03-05 Publication of FR2181738B1 publication Critical patent/FR2181738B1/fr

Status Expired legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Emergency Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Endocrinology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

FR7305356A 1972-02-23 1973-02-15 Expired FR2181738B1 (hu)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US00228743A US3833591A (en)	1972-02-23	1972-02-23	1,3,4,5-tetrahydropyrrolo(4,3,2-d,e)isoquinolines and related compounds

Publications (2)

Publication Number	Publication Date
FR2181738A1 true FR2181738A1 (hu)	1973-12-07
FR2181738B1 FR2181738B1 (hu)	1976-03-05

Family

ID=22858420

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR7305356A Expired FR2181738B1 (hu)	1972-02-23	1973-02-15

Country Status (6)

Country	Link
US (1)	US3833591A (hu)
JP (1)	JPS5516434B2 (hu)
BE (1)	BE795451A (hu)
DE (1)	DE2306605A1 (hu)
FR (1)	FR2181738B1 (hu)
GB (1)	GB1418354A (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3900477A (en) *	1973-11-06	1975-08-19	Ayerst Mckenna & Harrison	5-amino-and 5-hydrazinodihydropyrroloisoquinoline derivatives
US3978066A (en) *	1973-11-06	1976-08-31	Ayerst, Mckenna And Harrison Ltd.	Certain 4,6-dihydropyrrolotriazoline-quinoline derivatives
US3950343A (en) *	1973-11-06	1976-04-13	Ayerst, Mckenna And Harrison Ltd.	Pyrroloisoquinoline derivatives
US4029672A (en) *	1976-02-26	1977-06-14	American Hoechst Corporation	Aminoalkylpyrrolobenzoxazalkanes
JPS5729817U (hu) *	1980-07-26	1982-02-17
US4545935A (en) *	1983-09-12	1985-10-08	Iowa State University Research Foundation, Inc.	Amidoalkylation reactions of anilines
DE3525564A1 (de) *	1985-07-15	1987-02-05	Schering Ag	Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
US4978660A (en) *	1988-06-01	1990-12-18	Smithkline Beecham Corporation	α-adrenergic receptor antagonists
EP0344982B1 (en) *	1988-06-01	1994-11-23	Smithkline Beecham Corporation	Alpha-adrenergic receptor antagonists
EP0344980A3 (en) *	1988-06-01	1991-05-15	Smithkline Beecham Corporation	Alpha-adrenergic receptor antagonists
US4963547A (en) *	1988-06-01	1990-10-16	Smithkline Beecham Corporation	Alpha-andrenergic receptor antagonists and use thereas
DE68919280T2 (de) *	1988-06-01	1995-03-23	Smithkline Beckman Corp	Alpha-adrenergische Rezeptorantagonisten.
DE68917217T2 (de) *	1988-06-01	1994-12-01	Smithkline Beecham Corp	Alpha-adrenergische Rezeptorantagonisten.
US5006521A (en) *	1988-06-01	1991-04-09	Smithkline Beecham Corporation	α-adrenergic receptor antagonists and methods of use thereas
US4959360A (en) *	1988-06-01	1990-09-25	Smithkline Beecham Corporation	α-adrenergic receptor antagonists
US4981849A (en) *	1989-02-23	1991-01-01	Smithkline Beecham Corporation	Alpha-adrenergic receptor antagonists
US4981848A (en) *	1989-02-23	1991-01-01	Smithkline Beecham Corporation	Alpha-adrenergic receptor antagonists
US6765004B1 (en) *	1999-06-17	2004-07-20	Ortho-Mcneil Pharmaceutical, Inc.	Indoloazepines as vasopressin receptor antagonists
BRPI0808791A2 (pt) *	2007-03-13	2017-05-02	Biovitrum Ab (Publ)	derivados tricíclicos de isoquinolina para tratamento de obesidade

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3182071A (en) *	1961-06-27	1965-05-04	Warner Lambert Pharmaceutical	Acylated indole derivatives

0
- BE BE795451D patent/BE795451A/xx not_active IP Right Cessation
1972
- 1972-02-23 US US00228743A patent/US3833591A/en not_active Expired - Lifetime
1973
- 1973-01-26 GB GB423373A patent/GB1418354A/en not_active Expired
- 1973-02-10 DE DE2306605A patent/DE2306605A1/de not_active Ceased
- 1973-02-15 FR FR7305356A patent/FR2181738B1/fr not_active Expired
- 1973-02-16 JP JP1846373A patent/JPS5516434B2/ja not_active Expired

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3182071A (en) *	1961-06-27	1965-05-04	Warner Lambert Pharmaceutical	Acylated indole derivatives

Also Published As

Publication number	Publication date
JPS5516434B2 (hu)	1980-05-01
GB1418354A (en)	1975-12-17
US3833591A (en)	1974-09-03
FR2181738B1 (hu)	1976-03-05
BE795451A (fr)	1973-08-16
DE2306605A1 (de)	1973-09-06
JPS4892400A (hu)	1973-11-30

Publication	Publication Date	Title
FR2177843A1 (hu)	1973-11-09
JPS4947701A (hu)	1974-05-09
FR2181738B1 (hu)	1976-03-05
JPS4912758A (hu)	1974-02-04
FR2175866A1 (hu)	1973-10-26
JPS4934275A (hu)	1974-03-29
FR2236532B3 (hu)	1976-06-18
JPS4875370A (hu)	1973-10-11
JPS4964745U (hu)	1974-06-06
JPS4978900A (hu)	1974-07-30
JPS4917348A (hu)	1974-02-15
JPS4887032U (hu)	1973-10-22
JPS4896952U (hu)	1973-11-17
CH574627A5 (hu)	1976-04-15
CH567873A5 (hu)	1975-10-15
CH311672A4 (hu)	1973-12-14
CH574008B5 (hu)	1976-03-31
CH576596A5 (hu)	1976-06-15
CH575929A5 (hu)	1976-05-31
CH575803A5 (hu)	1976-05-31
CH574905A5 (hu)	1976-04-30
CH572194A5 (hu)	1976-01-30
CH574474A5 (hu)	1976-04-15
CH572805A5 (hu)	1976-02-27
CH572101A5 (hu)	1976-01-30

Legal Events

Date	Code	Title	Description
1985-12-20	ST	Notification of lapse